M. J. van de Vijver
Nature · 2002–2017
A researcher in the Science corpus: 12 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Who trusts M. J. van de Vijver overall
- Jelle J. Goeman
- H. Horlings
- Eric Bair
- Daniel R. Rhodes
- glenn. fung
- Aleix Prat
- J. Talmadge
- Tauno Metsalu
- R. Ramsay
- M. Cianfrocca
Papers from M. J. van de Vijver's perspective
Ordered by how strongly the researchers M. J. van de Vijver trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular portraits of human breast tumours (Nature)
- Diagnosis of multiple cancer types by shrunken centroids of gene expression
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- Repeated observation of breast tumor subtypes in independent gene expression data sets (Proceedings of the National Academy of Sciences of the United States of America)
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma (Clinical Cancer Research)
- The hallmarks of cancer (RNA Biology)
- Signatures of mutational processes in human cancer (Nature)
- Genes that mediate breast cancer metastasis to lung (Nature)
- Stromal gene expression predicts clinical outcome in breast cancer (Nature Medicine)
- Discovery and saturation analysis of cancer genes across 21 tumor types (Nature)
Their papers
- Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival (2011) — 747 citations
- Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis (2010) — 5,125 citations
- The landscape of cancer genes and mutational processes in breast cancer (2012) — 1,739 citations
- International network of cancer genome projects (2010) — 2,229 citations
- Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. (2006) — 2,034 citations
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer (2008) — 1,067 citations
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational-signatures (2017) — 946 citations
- Landscape of somatic mutations in 560 breast cancer whole genome sequences (2016) — 2,045 citations
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer (2008) — 595 citations
- Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas (2007) — 617 citations
- The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. (2002) — 878 citations
- A gene-expression signature as a predictor of survival in breast cancer. (2002) — 6,396 citations